363 related articles for article (PubMed ID: 34156443)
21. MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.
Lai B; Lee JE; Jang Y; Wang L; Peng W; Ge K
Nucleic Acids Res; 2017 Jun; 45(11):6388-6403. PubMed ID: 28398509
[TBL] [Abstract][Full Text] [Related]
22. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
Fagan RJ; Dingwall AK
Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
[TBL] [Abstract][Full Text] [Related]
23. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.
Kubo N; Chen PB; Hu R; Ye Z; Sasaki H; Ren B
Mol Cell; 2024 May; 84(9):1742-1752.e5. PubMed ID: 38513661
[TBL] [Abstract][Full Text] [Related]
24. Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription.
Lee S; Roeder RG; Lee JW
Prog Mol Biol Transl Sci; 2009; 87():343-82. PubMed ID: 20374709
[TBL] [Abstract][Full Text] [Related]
25. Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity.
Ning H; Huang S; Lei Y; Zhi R; Yan H; Jin J; Hu Z; Guo K; Liu J; Yang J; Liu Z; Ba Y; Gao X; Hu D
Nat Commun; 2022 Nov; 13(1):6578. PubMed ID: 36323669
[TBL] [Abstract][Full Text] [Related]
26. Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.
Boileau RM; Chen KX; Blelloch R
Genome Biol; 2023 Mar; 24(1):41. PubMed ID: 36869380
[TBL] [Abstract][Full Text] [Related]
27. WRAD: enabler of the SET1-family of H3K4 methyltransferases.
Ernst P; Vakoc CR
Brief Funct Genomics; 2012 May; 11(3):217-26. PubMed ID: 22652693
[TBL] [Abstract][Full Text] [Related]
28. Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis.
Yang W; Ernst P
Curr Opin Hematol; 2017 Jul; 24(4):322-328. PubMed ID: 28375985
[TBL] [Abstract][Full Text] [Related]
29. Interplay of BAF and MLL4 promotes cell type-specific enhancer activation.
Park YK; Lee JE; Yan Z; McKernan K; O'Haren T; Wang W; Peng W; Ge K
Nat Commun; 2021 Mar; 12(1):1630. PubMed ID: 33712604
[TBL] [Abstract][Full Text] [Related]
30. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.
Yan J; Chen SA; Local A; Liu T; Qiu Y; Dorighi KM; Preissl S; Rivera CM; Wang C; Ye Z; Ge K; Hu M; Wysocka J; Ren B
Cell Res; 2018 Feb; 28(2):204-220. PubMed ID: 29313530
[TBL] [Abstract][Full Text] [Related]
31. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.
Rickels R; Herz HM; Sze CC; Cao K; Morgan MA; Collings CK; Gause M; Takahashi YH; Wang L; Rendleman EJ; Marshall SA; Krueger A; Bartom ET; Piunti A; Smith ER; Abshiru NA; Kelleher NL; Dorsett D; Shilatifard A
Nat Genet; 2017 Nov; 49(11):1647-1653. PubMed ID: 28967912
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations of MLL4/COMPASS induce cytoplasmic localization providing molecular insight into cancer prognosis and treatment.
Zhao Z; Aoi Y; Philips CN; Meghani KA; Gold SR; Yu Y; John LS; Qian J; Zeidner JM; Meeks JJ; Shilatifard A
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2310063120. PubMed ID: 38113256
[TBL] [Abstract][Full Text] [Related]
33. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.
Lee J; Kim DH; Lee S; Yang QH; Lee DK; Lee SK; Roeder RG; Lee JW
Proc Natl Acad Sci U S A; 2009 May; 106(21):8513-8. PubMed ID: 19433796
[TBL] [Abstract][Full Text] [Related]
34. The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program.
Wang X; Rosikiewicz W; Sedkov Y; Mondal B; Martinez T; Kallappagoudar S; Tvardovskiy A; Bajpai R; Xu B; Pruett-Miller SM; Schneider R; Herz HM
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35820704
[TBL] [Abstract][Full Text] [Related]
35. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
[TBL] [Abstract][Full Text] [Related]
36. An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells.
Cao K; Collings CK; Morgan MA; Marshall SA; Rendleman EJ; Ozark PA; Smith ER; Shilatifard A
Sci Adv; 2018 Jan; 4(1):eaap8747. PubMed ID: 29404406
[TBL] [Abstract][Full Text] [Related]
37. Regulation of H3K4 trimethylation via Cps40 (Spp1) of COMPASS is monoubiquitination independent: implication for a Phe/Tyr switch by the catalytic domain of Set1.
Takahashi YH; Lee JS; Swanson SK; Saraf A; Florens L; Washburn MP; Trievel RC; Shilatifard A
Mol Cell Biol; 2009 Jul; 29(13):3478-86. PubMed ID: 19398585
[TBL] [Abstract][Full Text] [Related]
38. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis.
Lee JE; Park YK; Park S; Jang Y; Waring N; Dey A; Ozato K; Lai B; Peng W; Ge K
Nat Commun; 2017 Dec; 8(1):2217. PubMed ID: 29263365
[TBL] [Abstract][Full Text] [Related]
39. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.
Wang P; Lin C; Smith ER; Guo H; Sanderson BW; Wu M; Gogol M; Alexander T; Seidel C; Wiedemann LM; Ge K; Krumlauf R; Shilatifard A
Mol Cell Biol; 2009 Nov; 29(22):6074-85. PubMed ID: 19703992
[TBL] [Abstract][Full Text] [Related]
40. ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.
Kim DH; Lee J; Lee B; Lee JW
Mol Endocrinol; 2009 Oct; 23(10):1556-62. PubMed ID: 19556342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
